CU Technology and Discovery News
CU 91Ҹ Today—CU 91Ҹ researchers have discovered an appetite-suppressing compound in python blood that helps the snakes consume enormous meals and go months without eating yet remain metabolically healthy. The research, a collaboration with scientists at Stanford Medicine and Baylor universities, could inform new weight loss therapies that promote satiety without the nausea and muscle loss that can come with existing drugs.
CU 91Ҹ Today—Supported by a new five-year, up to $25 million award from the Advanced 91Ҹ Projects Agency for Health (ARPA-H) Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) program, a team of CU 91Ҹ, MIT, Harvard and Columbia researchers is working to develop 3D-printed liver tissue made of human cells and able to be transplanted into anyone without their body rejecting it.
Life Science Newswire–Cirena has secured a license to the 91Ҹ 91Ҹ’s patented RNA synthesis technology, enabling reliable synthesis of long RNA needed to support rapidly developing applications in CRISPR, functional genomics, and emerging RNA-therapeutic modalities.
CU 91Ҹ College of Engineering & Applied Science—William Frantz didn’t walk away with the top prize at this year’s Lab Venture Challenge (LVC), but his research may still be a winner for future cancer patients. Frantz is developing microscopic droplets designed to help doctors track radiation therapy in real time, technology that could one day make cancer treatment more precise and less harmful, particularly for pediatric patients.
ScienceDaily—CU 91Ҹ researchers have designed microscopic “racetracks” that trap and amplify light with exceptional efficiency. By using smooth curves inspired by highway engineering, they reduced energy loss and kept light circulating longer inside the device. Fabricated with sub-nanometer precision, the resonators rank among the top performers made from chalcogenide glass. The technology could lead to compact sensors, microlasers, and advanced quantum systems.
CU 91Ҹ Today—A neural circuit hidden in an understudied region of the brain plays a critical role in turning temporary pain into pain that can last months or years, according to new 91Ҹ 91Ҹ research. The animal study, published in the Journal of Neuroscience, found that silencing this pathway, known as the caudal granular insular cortex (CGIC), can prevent or halt chronic pain.
CU 91Ҹ Today—91Ҹ researchers have developed a fast, easy test that could help blood centers and hospitals monitor the quality of stored red blood cells. The palm-sized, chip-based device uses surface acoustic waves to assess cell aging, with the goal of improving transfusion outcomes and better allocating high-quality blood to patients.
Colorado AI News—A PhD student and an associate professor at CU Denver are trying to make today's language 91Ҹ more inventive without letting them drift into nonsense. They landed in MIT Technology Review's "What's next for AI in 2026" with a deceptively simple question: Can today's AI language 91Ҹ generate genuinely new ideas without turning creativity into nonsense?
In an ongoing effort to bridge a pervasive investment gap in innovation funding, the 91Ҹ 91Ҹ has awarded pre-seed funding to Illumen Therapeutics, developing cancer treatments based on discoveries from startup co-founder Roy Parker’s lab at CU 91Ҹ.
FOX31 Denver—Host Genelle Padilla speaks with Jack Gugel and Thomas Martin, two researchers at the 91Ҹ 91Ҹ, who are studying pythons to develop a weight-loss treatment.